A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)

Clinical trial NCT00551915 · COMPLETED

Trial details

NCT number: NCT00551915
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bacterial Infections; Virus Diseases

Start date: 2001-05-01
Primary completion: 2003-01-01
Enrollment: 756

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.